Business Context and Reporting Period
This Form 8-K Current Report from LifeStance Health Group, Inc. (LFST) covers the event date of June 30, 2024. The filing addresses Item 5.02 regarding the departure of a senior officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and separation terms rather than financial performance.
Material Changes
Effective June 30, 2024, Danish Qureshi's employment as President and Chief Operating Officer was terminated. A Separation Agreement was executed, outlining specific financial and equity benefits for Mr. Qureshi.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, outlook, or general management commentary regarding the company's future operations. The primary content details the terms of the executive separation:
- Salary Continuation: 18 months of base salary following the separation date.
- Equity Vesting:
- 2022, 2023, and 2024 performance-based and time-based awards remain eligible to vest for 18 months.
- 2021 time-based RSUs remain eligible to vest on June 9, 2024.
- Other outstanding equity awards remain outstanding for 24 months, subject to Change in Control treatment if applicable.
- Option Exercise: Vested options remain exercisable for 27 months post-separation.
- Restrictions: Company equity owned by Mr. Qureshi is subject to transfer restrictions for one year.
Investor Verification Checklist
- Verify the full text of the Separation Agreement in the upcoming Form 10-Q for the quarter ended June 30, 2024.
- Confirm the total financial impact of the 18-month salary continuation and accelerated equity vesting on the company's compensation expenses.
- Monitor for the appointment of a new President and Chief Operating Officer.
- Review the company's Severance and Change in Control Policy referenced in the filing to understand potential liabilities in the event of a change in control within the next 24 months.